Find by identifier
CAS number index
39,377 CAS Registry Numbers in numeric order. A number with several grades opens a comparison page, a single match opens the product.
| CAS number | Substance | Listings |
|---|---|---|
| 169327-87-1 | Fluazinam Impurity 1 | 1 |
| 169396-92-3 | Fmoc-PNA-T-OH, 98% | 1 |
| 169506-15-4 | 2-(2-Ethoxyphenoxy)ethyl Methanesulfonate | 1 |
| 169566-81-8 | Fmoc-alpha-methyl-L-Valine | 1 |
| 169590-41-4 | Deracoxib | 1 |
| 169590-42-5 | Celecoxib | 2 |
| 169869-90-3 | Exatecan Mesylate | 1 |
| 169899-17-6 | (Z)-N-(4-Chlorobut-2-en-1-yl)-2-((furan-2-ylmethyl)sulfinyl)acetamide | 1 |
| 169899-18-7 | (Z)-1-((2-((4-(2-((Furan-2-ylmethyl)sulfinyl)acetamido)but-2-en-1-yl)oxy)pyridin-4-yl)methyl)piperidine 1-oxide | 1 |
| 169905-10-6 | 2-Chloromethyl-3,4-dimethoxypyridine | 1 |
| 170011-57-1 | tert-Butyl 4-(4-aminophenyl)piperidine-1-carboxylate | 1 |
| 170082-15-2 | Clonazepam D4 | 1 |
| 170098-38-1 | Alvimopan (dihydrate) | 1 |
| 170105-16-5 | Imidafenacin | 1 |
| 170161-27-0 | Plerixafor Tri Boc Impurity | 1 |
| 170170-50-0 | 1-[4-[3-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]propoxy]-3-methoxyphenyl]-ethanone | 1 |
| 170210-42-1 | Ketoconazole Hydroxymethyl Impurity | 1 |
| 170210-49-8 | ((2S,4R)-2-((1H-Imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol | 1 |
| 170359-61-2 | 6,7,8,9-Dehydro Paliperidone Dihydrochloride | 1 |
| 170569-87-6 | Desmethyl Celecoxib | 1 |
| 170569-88-7 | Mavacoxib | 1 |
| 170569-99-0 | Celecoxib EP Impurity C | 1 |
| 170570-01-1 | Celecoxib EP Impurity A | 1 |
| 170570-09-9 | 2-Methyl-Celecoxib | 1 |
| 170571-00-3 | Hydroxy Celecoxib | 1 |
| 170571-01-4 | Celecoxib carboxylic acid | 1 |
| 170572-49-3 | 3-Fluoro-p-tolunitrile, 98% | 1 |
| 170643-02-4 | FMOC-D-allo-Thr(tBu)-OH | 1 |
| 170727-59-0 | Loratadine EP Impurity E | 1 |
| 170727-67-0 | (3-(3-Chlorophenethyl)pyridin-2-yl)(1-methylpiperidin-4-yl)methanol | 1 |
| 170729-76-7 | Aprepitant EP Impurity A | 1 |
| 170729-79-0 | 2-(R)-[1-(S)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine | 1 |
| 170729-80-3 | Aprepitant | 1 |
| 170791-09-0 | Candesartan Cilexetil EP Impurity H | 1 |
| 170848-34-7 | Boc-beta-iodo-D-Ala-OMe | 1 |
| 170851-70-4 | Ipamorelin | 1 |
| 170902-81-5 | (1S,2R,3S)-Aprepitant | 1 |
| 170908-81-3 | DOTA-NHS ester, 90%+ | 2 |
| 170911-92-9 | tert-Butyl 4-(4-aminophenyl)piperazine-1-carboxylate | 1 |
| 170985-61-2 | Posaconazole 2R,3R Diastereoisomer | 2 |
| 170985-85-0 | Posaconazole Impurity 15 | 1 |
| 170985-86-1 | O-Benzyl Posaconazole | 1 |
| 171049-35-7 | N-Boc-4,4'-bipiperidine | 1 |
| 171050-06-9 | 3-Cyano-4-fluorobenzoic Acid | 1 |
| 171058-17-6 | 1-Hexyl-3-methyl imidazolium chloride, 98% | 4 |
| 171058-18-7 | 1-Decyl-3-methylimidazolium chloride, 96% | 1 |
| 171178-45-3 | tert-Butyl (6-chloropyridin-3-yl)carbamate | 1 |
| 171199-96-5 | 17-epi-Testosterone-d3 | 1 |
| 171228-49-2 | Posaconazole | 1 |
| 171228-50-5 | Posaconazole Related Compound A | 1 |
| 171228-51-6 | Posaconazole 2R,3S Diastereoisomer | 1 |
| 171262-17-2 | Alachlor OA | 1 |
| 171335-80-1 | Exatecan | 1 |
| 171338-27-5 | Aprepitant M2 Metabolite (1R,2R,3S)-Isomer | 1 |
| 171338-33-3 | Aprepitant Desfluoro Spot-1 | 1 |
| 171367-22-9 | Metoclopramide EP Impurity G | 1 |
| 171370-49-3 | Zileuton - Impurity A | 1 |
| 171416-67-4 | Ligand 16 | 1 |
| 171416-68-5 | Ligand 17 | 1 |
| 171440-18-9 | Dexrabeprazole sodium | 1 |
| 171440-19-0 | (S)-Rabeprazole Sodium Salt | 1 |
| 171482-05-6 | (2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride | 1 |
| 171489-03-5 | Tadalafil Desmethylene Impurity | 1 |
| 171489-59-1 | Chloropretadalafil | 1 |
| 171500-79-1 | Dalbavancin | 1 |
| 171500-80-4 | Dalbavancin A1 | 1 |
| 171500-81-5 | Dalbavancin A0 | 1 |
| 171500-82-6 | Dalbavancin B1 | 1 |
| 171567-86-5 | Daclatasvir MOC-D-Valine | 1 |
| 171596-27-3 | Tadalafil EP Impurity A | 1 |
| 171596-28-4 | Tadalafil EP Impurity C | 1 |
| 171596-29-5 | Tadalafil | 2 |
| 171596-31-9 | N-Butyl Nortadalafil | 1 |
| 171596-36-4 | N-Desmethyl Tadalafil | 1 |
| 171596-42-2 | (1S,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate | 1 |
| 171596-43-3 | (1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester | 1 |
| 171599-83-0 | Sildenafil Citrate | 2 |
| 171611-11-3 | Lithium bis(fluorosulfonyl)imide, 98% | 1 |
| 171623-02-2 | Lacosamide EP Impurity F | 1 |
| 171674-89-8 | Nitidanin | 1 |
| 171721-00-9 | 1,3,5-Tri-O-benzoyl-2-deoxy-2-fluoro-α-L-arabinofuranose | 1 |
| 171722-92-2 | 4-Piperidyl n-(2-biphenyl)carbamate | 1 |
| 171723-80-1 | 1 Benzylpiperidin 4 yl 1 1 biphenyl 2 ylcarbamate | 1 |
| 171752-68-4 | (1R,3R)-9H-Pyrido[3,4-B]indole-3-carboxylic acid, 1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl), methyl ester, hydrochloride | 1 |
| 171860-66-5 | sec-Butylzinc bromide solution, 0.5 M in THF | 1 |
| 171887-01-7 | Abacavir Impurity 8 | 1 |
| 171887-02-8 | N'-(2-Amino-4,6-dichloro-5-pyrimidinyl)-N,N-dimethylmethanimidamide | 1 |
| 171887-03-9 | 2-Amino-4,6-dichloro-5-formamidopyrimidine | 1 |
| 171887-04-0 | (1R-Cis)-N-[2-amino-4-chloro-6-[[4-(hydroxymethyl)-2-cyclopenten-1-yl]amino]-5-pyrimidinyl]-formamide | 1 |
| 171897-72-6 | Iodixanol EP Impurity G | 1 |
| 171897-73-7 | Iodixanol EP Impurity F | 1 |
| 171897-74-8 | Iodixanol EP Impurity C | 1 |
| 171926-87-7 | 2-Debenzoyl-2-tigloyl 10-Deacetyl Baccatin III | 1 |
| 172015-79-1 | Abacavir USP Related Compound C | 1 |
| 172018-16-5 | 13-epi-10-Deacetyl Baccatin III | 1 |
| 172152-35-1 | Desoxy Ilaprazole | 1 |
| 172152-36-2 | Ilaprazole | 1 |
| 172152-37-3 | Ilaprazole Sulfone | 1 |
| 172152-53-3 | 5-(1H-Purrole-1-yl)-2-marcapto- benzimidazole | 1 |
| 172155-07-6 | Perfluoro-3,7-dimethyloctanoic acid | 1 |
| 172222-30-9 | Grubbs catalyst, 1st generation, 97% | 1 |
| 172282-50-7 | 4-(Difluoromethoxy)-1,2-benzenediamine | 1 |
| 172336-32-2 | Pitavastatin Ethyl ester | 1 |
| 172426-86-7 | Despropylene Gatifloxacin | 1 |
| 172426-88-9 | 7-Amino-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid | 1 |
| 172430-45-4 | Desmethyl Ranolazine | 1 |
| 172430-46-5 | O-Desaryl Ranolazine | 1 |
| 172430-48-7 | Ranolazine Impurity-21 | 1 |
| 172471-65-7 | Glucose-6-acrylate | 1 |
| 172529-93-0 | Dimethyl 2-[2-(2-amino-6-chloropurin-9-yl)ethyl]malonate | 1 |
| 172587-60-9 | ((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol | 1 |
| 172603-05-3 | N-3-Piperidinylcarbamic Acid 1,1-Dimethylethyl Ester | 1 |
| 172617-84-4 | N-Demethylazithromycin | 1 |
| 172617-99-1 | Eucalyptone | 1 |
| 172669-64-6 | Glycyl-L-Glutamine Monohydrate, cell culture tested | 1 |
| 172673-20-0 | Fosaprepitant | 1 |
| 172673-23-3 | Aprepitant N-Oxide | 1 |
| 172732-52-4 | 2-(1,3,2-Dioxaborinan-2-yl)benzonitrile, 98% | 1 |
| 172792-37-9 | (2R,3S,5R)-5-(6-Amino-2-chloro-7H-purin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol | 1 |
| 172822-01-4 | (3-(((2S,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid | 1 |
| 172822-28-5 | 1R,2S,3S Aprepitant | 1 |
| 172822-29-6 | ent-Aprepitant | 1 |
| 172875-53-5 | Ethyl Olmesartan Medoxomil (Stage -1) | 1 |
| 172875-59-1 | N-Trityl Olmesartan Ethyl Ester | 1 |
| 172875-98-8 | Dehydro Olmesartan | 1 |
| 172922-52-0 | 5-beta-Dihydro Finasteride | 1 |
| 172924-51-5 | [N-[Phenyl[2-[[[(1S,2R)-1-(phenylmethyl)-2-pyrrolidinyl-kappaN]carbonyl]amino-kappaN]phenyl]methylene]glycinato(2-)-kappaN,kappaO]nickel | 1 |
| 172953-70-7 | N-Ethyl-1-(2-(trifluoromethyl)phenyl)propan-2-amine | 1 |
| 172960-62-2 | Metazachlor ESA | 1 |
| 172975-69-8 | 3,5-Dimethylphenylboronic acid, 98% | 1 |
| 173070-31-0 | 2-(6-Methoxy-3-(1-(pyridin-2-yl)ethyl)-1H-inden-2-yl)-N-methylethan-1-amine | 1 |
| 173075-45-1 | Ganoderic acid DM | 1 |
| 173101-47-8 | N-Debenzoyl-N-propanoyl-10-deacetyl Paclitaxel | 1 |
| 173101-54-7 | Paclitaxel EP Impurity A | 1 |
| 173101-56-9 | Paclitaxel EP Impurity P | 1 |
| 173101-59-2 | N-Debenzoyl-N-Propanoyl-10-Deacetylpaclitaxel | 1 |
| 173142-47-7 | (S)-Methyl 5-methoxy-3,4-dihydro-2H-pyrrole-2-carboxylate | 1 |
| 173159-57-4 | Foramsulfuron | 1 |
| 173174-07-7 | Olopatadine N-Oxide | 1 |
| 173194-95-1 | 6-Hydroxynaphthalene-2-boronic Acid | 1 |
| 173308-19-5 | 2-Aminoethyl-mono-amide-DOTA-tris(tBu ester), 98% | 1 |
| 173323-23-4 | 2-[2-[2-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)ethoxy]ethoxy]acetic Acid | 1 |
| 173334-58-2 | Aliskiren Hemifumarate | 1 |
| 173336-76-0 | 4-Bromo-1-methoxy-2-(3-methoxypropoxy)benzene | 1 |
| 173352-21-1 | Afobazole | 1 |
| 173400-13-0 | Aliskiren Carboxylic Acid | 1 |
| 173414-65-8 | 1H-2-Benzopyran-1-one,6,7-dimethoxy-3-propyl | 1 |
| 173427-03-7 | Dihydroartemisinin Impurity F | 1 |
| 173470-70-7 | 2,2-Dichloroacetic Acid-1-13C | 1 |
| 173522-96-8 | Lamivudine Salicylate | 1 |
| 173532-15-5 | N-Acetyl Tizanidine | 1 |
| 173584-44-6 | (S)-Indoxacarb | 1 |
| 173606-11-6 | Octreotide EP Impurity H | 1 |
| 173658-50-9 | Lurasidone Trans (S,S) Mesylate | 1 |
| 173662-97-0 | Mandestrobin | 1 |
| 173676-54-5 | 4-Chloro-N-(4-methoxybenzyl)-2-(trifluoroacetyl)aniline | 1 |
| 173676-59-0 | 4-Chloro-2-(trifluoroacetyl)aniline Hydrochloride Hydrate | 1 |
| 173676-60-3 | Efavirenz Descarbonyl Benzyl impurity | 1 |
| 173829-09-9 | Lamivudine EP Impurity A | 1 |
| 173837-65-5 | 2-(2,4-Difluorophenyl)-1,2,3-propanetriol | 1 |
| 173851-66-6 | Amylmetacresol EP Impurity E | 1 |
| 173851-73-5 | Amylmetacresol EP Impurity I | 1 |
| 173903-47-4 | Tizoxanide | 1 |
| 173937-91-2 | Atrasentan | 1 |
| 173990-76-6 | Ropinirole EP Impurity D (HCL) | 1 |
| 174072-89-0 | Ethyl-2-Amino-4-methyl-5-(4-nitro-phenyl)-thiophene-3-carboxylate | 1 |
| 174155-70-5 | 2-Amino-β-methyl-9H-purine-9-butanol 9-Acetate | 1 |
| 174227-14-6 | Bosentan USP Related Compound B | 1 |
| 174264-50-7 | Raloxifene-6-Glucuronide | 1 |
| 174265-12-4 | 2-Bromo-5-chlorobenzaldehyde, 95% | 1 |
| 174316-71-3 | Boc-isonipecotic acid, 98%+ | 1 |
| 174391-69-6 | Amoxicillin Trimer | 1 |
| 174422-72-1 | [4-(N-Maleimidomethyl)]cyclohexane-1-carboxylhydrazide HCl | 1 |
| 174501-64-5 | 1-Butyl-3-methylimidazolium hexafluorophosphate, ≥98.5% | 3 |
| 174501-65-6 | 1-Butyl-3-methylimidazolium tetrafluoroborate, 98% | 4 |
| 174583-84-7 | Lafutidine Sulfone | 1 |
| 174607-68-2 | (R)-4-Benzyl Albuterol | 1 |
| 174610-17-4 | Rizatriptan | 1 |
| 174645-81-9 | 1-Butyl-3-methylimidazolium hexafluoroantimonate, ≥97% | 1 |
| 174649-09-3 | Linezolid USP Related Compound D | 1 |
| 174671-46-6 | Tavaborole | 1 |
| 174671-88-6 | 4-Fluorobenzo[c][1,2]oxaborol-1(3H)-ol | 1 |
| 174675-49-1 | Sodium perfluoro-1-tridecanesulfonate | 1 |
| 174756-44-6 | (R)-Safinamide | 1 |
| 174756-45-7 | 2-Hydroxymethyl Olanzapine | 1 |
| 174756-99-1 | Moxidectin EP Impurity K | 1 |
| 174775-48-5 | Ethyl 5-amino-1-benzofuran-2-carboxylate | 1 |
| 174794-02-6 | Olanzapine N-Oxide | 1 |
| 174819-21-7 | N-4-Methoxybenzyl efavirenz | 1 |
| 174894-85-0 | 3-(Ethoxymethyl)benzoic acid | 1 |
| 174899-66-2 | 1-Butyl-3-methylimidazolium trifluoromethanesulphonate, ≥95% (H-NMR) | 2 |
| 174899-72-0 | 1-Ethyl-2,3-Dimethylimidazolium Trifluoromethanesulfonate For Electrochemistry, 99.0% (Hplc) | 1 |
| 174899-82-2 | 1-Ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide, ≥97% (NMR) | 2 |
| 174899-83-3 | 1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide, for HPLC 99% | 2 |
| 174899-86-6 | 1-(2-Hydroxyethyl)-3-methylimidazolium bis(trifluoromethanesulfonyl)imide, 99% | 1 |
| 174899-94-6 | 1-Butyl-3-methylimidazolium trifluoroacetate, 97% | 1 |
| 174953-30-1 | (4S)-4-Methyl-1,3,2 lambda 6-dioxathiolane-2,2-dione | 1 |
| 174972-79-3 | Parishin B | 1 |
| 175013-18-0 | Pyraclostrobin | 1 |
| 175026-96-7 | NQDI-1, ≥98% (HPLC) | 1 |
| 175032-97-0 | Cefotaxime EP Impurity F | 1 |
| 175131-60-9 | Levomilnacipran Hydrochloride | 1 |
| 175131-61-0 | L-Milnacipran Hydrochloride | 1 |
| 175137-61-8 | Propanesulfonylacetonitrile | 1 |
| 175213-46-4 | tert-Butyl 4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate | 1 |
| 175217-20-6 | Silthiofam | 1 |
| 175278-17-8 | 2-Bromo-4-(trifluoromethoxy)aniline | 1 |
| 175278-30-5 | 4-Bromo-2-ethyl-1-iodobenzene | 1 |
| 175422-04-5 | 2,6-Dibromo-4-nitropyridine, 97% | 1 |
| 175453-07-3 | Fmoc-3-(3-pyridyl)-L-alanine | 1 |
| 175453-08-4 | Fmoc-Phe(4-Cl)-OH | 1 |
| 175460-94-3 | Raloxifene Impurity 9 | 1 |
| 175481-26-2 | Lacosamide (racemate) | 1 |
| 175481-36-4 | Lacosamide | 1 |
| 175481-37-5 | Lacosamide EP Impurity A | 1 |
| 175481-38-6 | Lacosamide EP Impurity F | 1 |
| 175481-39-7 | Lacosamide EP Impurity E | 1 |
| 175591-09-0 | Tapentadol Hydrochloride | 1 |
| 175591-17-0 | O-Methyl Tapentadol Hydrochloride | 1 |
| 175591-22-7 | Tapentadol EP Impurity E | 1 |
| 175591-23-8 | Tapentadol | 1 |
| 175596-01-7 | Methyl 4-cyano-2-fluorobenzoate | 1 |
| 175613-38-4 | 9-Hydroxymethyl-10-hydroxy Camptothecin | 1 |
| 175712-02-4 | Posaconazole Impurity 21 | 1 |
| 175865-59-5 | Valganciclovir Hydrochloride | 1 |
| 175865-60-8 | Valganciclovir | 1 |
| 175870-21-0 | Dehydro Silodosin | 1 |
| 175870-40-3 | Benzyl Silodosin | 1 |
| 176022-03-0 | (3S,4R)-1-Methyl-4-phenyl-3-piperidinemethanol | 1 |
| 176110-81-9 | Sodium(R)-5-(1,2-dithiolan-3-yl)pentanoate | 1 |
| 176161-24-3 | Maribavir | 1 |
| 176161-49-2 | (2R,3S,4R,5S)-2-(5,6-Dichloro-2-(isopropylamino)-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | 1 |
| 176161-55-0 | 5,6-Dichloro-N-isopropyl-1H-benzo[d]imidazol-2-amine | 1 |
| 176168-78-8 | Cis-Terbinafine Hydrochloride | 1 |
| 176219-04-8 | Omeprazole Impurity E | 1 |
| 176219-12-8 | 4,5'-Di(desmethyl) Omeprazole Sulfide | 1 |
| 176220-84-1 | 2,2-Bisnalmefene | 1 |
| 176252-20-3 | Plerixafor Impurity 1 (Hydroxy Impurity) | 1 |
| 176254-10-7 | Levonorgestrel EP Impurity S | 1 |
| 176258-88-1 | Levothyroxine Acetamide Impurity | 1 |
| 176302-02-6 | Pre-Calcipotriol | 1 |
| 176308-57-9 | 2-(tert-butyl)-4-(2-hydroxyethyl)phenol | 1 |
| 176317-02-5 | 1-Bromo-2,3,4-trifluorobenzene | 1 |
| 176365-26-7 | N-(Tert-Butyl)-N`-(3,5-dimethylbenzoyl)-3-methoxy-2-methylbenzohydrazide | 1 |
| 176365-28-9 | N-(Tert-Butyl)-3-methoxy-n`-(3-methoxy-2-methylbenzoyl)-2-methylbenzohydrazide | 1 |
| 176447-94-2 | N-Desmethyl Dofetilide | 1 |
| 176508-81-9 | 4-Cyano-3-fluorobenzoic acid | 1 |
| 176515-52-9 | Irinotecan Keto Impurity | 1 |
| 176655-56-4 | Ritonavir EP Impurity E | 1 |
| 176721-01-0 | α-(2,3-Dimethylphenyl)-1-(trityl)-1H-imidazole-4-methanol | 1 |
Or browse by name